Corrigendum: Research to the N-power: The strengths of networked clinical collaboration in Spain (American Journal of Gastroenterology (2017) DOI: 10.1038/ajg.2017.416);Research to the N-Power: The Strengths of Networked Clinical Collaboration in Spain

American Journal of Gastroenterology

Volumn 112, Issue 12, 2017, Pages 1761-1764

  McNicholl, Adrian G ^a,b   Gisbert, Javier P ^b,c  

^a AEG   (Canada)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c Spanish Working Group on Crohn’s Disease and Ulcerative Colitis ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COOPERATION; FUNDING; GASTROENTEROLOGY; HUMAN; MEDICAL RESEARCH; MEDICAL RESEARCH NETWORKING; PLANNING; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; SPAIN; INTERSECTORAL COLLABORATION; MEDICAL SOCIETY; ORGANIZATION AND MANAGEMENT; SOCIAL NETWORK;

BIOMEDICAL RESEARCH; GASTROENTEROLOGY; HUMANS; INTERSECTORAL COLLABORATION; SOCIAL NETWORKING; SOCIETIES, MEDICAL; SPAIN;

EID: 85041461277     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2017.476     Document Type: Erratum

References (21)

1. Bordons M, Gómez I, Fernández M et al. Local, domestic and international scientific collaboration in biomedical research. Scientometrics 1996;37:279–95.
2. Morillo F, Díaz-Faes AA, González-Albo B et al. Do networking centres perform better? An exploratory analysis in Psychiatry and Gastroenterology/ Hepatology in Spain. Scientometrics 2014;98:1401–16.
3. Bennett LM, Gadlin H. Collaboration and team science: from theory to practice. J Investig Med 2012;60:768–75.
4. Little MM, St Hill CA, Ware KB et al. Team science as interprofessional collaborative research practice: a systematic review of the science of team science literature. J Investig Med 2017;65:15–22.
5. Spanish Foundation for Science and Technology (FECYT). ICONO Analysis: R&D Statistics 2015-2016. FECYT: Madrid, Spain, 2017; https://icono.fecyt.es/.
6. OECD. Main Science and Technology Indicators OECD: 2017, 7 February 2017
7. Vela C. Turn Spain’s budget crisis into an opportunity. Nature 2012;486:7.
8. Corpas M. Spanish cuts: more economic damage. Nature 2012;487:38.
9. Spanish Observatory of R&D (ICONO). Bibliometric Indicators of Spanish Scientific Activity 2005-2014. In: Spanish Foundation for Science and Technology (FECYT) (eds). Madrid, Spain, 2016.
10. Gonzalez Alcaide G, Ramos Rincon JM, Gisbert JP. [Scientific collaboration and research areas in Gastroenterologia y Hepatologia and Revista Espanola de Enfermedades Digestivas (2000-2009)]. Gastroenterol Hepatol 2010;33:670–80.
11. Ordás I, Domènech E, Mañosa M et al. Long-term efficacy and safety of cyclosporine in a cohort of steroid-refractory acute severe ulcerative colitis patients from the ENEIDA Registry (1989-2013): a nationwide multicenter study. Am J Gastroenterol 2017;112:1709–1718.
12. Chaparro M, Ramas M, Benitez JM et al. Extracolonic cancer in inflammatory bowel disease: data from the GETECCU Eneida Registry. Am J Gastroenterol 2017;112:1135–43.
13. Iborra M, Perez-Gisbert J, Bosca-Watts MM et al. Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naive and non-naive patients. J Gastroenterol 2017;52:788–99.
14. Guerra I, Perez-Jeldres T, Iborra M et al. Incidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in patients with inflammatory bowel disease: a nationwide cohort study. Inflamm Bowel Dis 2016;22:894–901
15. Gordillo J, Cabre E, Garcia-Planella E et al. Thiopurine therapy reduces the incidence of colorectal neoplasia in patients with ulcerative colitis. data from the ENEIDA Registry. J Crohns Colitis 2015;9:1063–70.
16. Canas-Ventura A, Marquez L, Ricart E et al. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment. J Crohns Colitis 2014;8:1287–93.
17. Cabre E, Manosa M, Garcia-Sanchez V et al. Phenotypic concordance in familial inflammatory bowel disease (IBD). Results of a nationwide IBD Spanish database. J Crohns Colitis 2014;8:654–61.
18. Andreu M, Marquez L, Domenech E et al. Disease severity in familial cases of IBD. J Crohns Colitis 2014;8:234–9.
19. Nunes T, Etchevers MJ, Domenech E et al. Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era. Aliment Pharmacol Ther 2013;38:752–60.
20. Garcia-Bosch O, Gisbert JP, Canas-Ventura A et al. Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome. J Crohns Colitis 2013;7:717–22.
21. Harris PA, Taylor R, Thielke R et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81.